Manufacturer record
Rivpra Formulation Pvt.Ltd.Plot No.8: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Rivpra Formulation Pvt.Ltd.Plot No.8 (Uttarakhand) were declared Not of Standard Quality between September 2025 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
5 records linked to Rivpra Formulation Pvt.Ltd.Plot No.8 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Glimepiride Tablets IP 4mg | T2512152Mfg 2025-12 · Exp 2027-11 | Does not conform to IP Standards with respect to Dissolution TestDissolution | Food & Drugs Laboratory Bambolim, GoaState lab | Jul 2026 |
| Ambroxol Hydrochloride, Guaiphenesin & Terbutaline Sulphate Syrup | L-2508007Mfg 2025-08 · Exp 2027-07 | The sample does not conform to claim as per Patent and Proprietary in respect to the Test of Total fungal countOther | RDTL, ChandigarhCDSCO lab | Feb 2026 |
| Ambroxol Hydrochloride, Guaiphenesin & Terbutaline Sulphate Syrup | L-2508003Mfg 2025-08 · Exp 2027-07 | The sample does not conform to claim as per Patent and Proprietary in respect to the Test of Total fungal countOther | RDTL, ChandigarhCDSCO lab | Feb 2026 |
| Ciprofloxacin Tablets U.S.P. 500 mg.. | T-2408090Mfg 2024-08 · Exp 2026-07 | The sample does not conform to claim as per U.S.P. with respect to the test for "Dissolution" of Ciprofloxacin.Dissolution | RDTL, GuwahatiCDSCO lab | Nov 2025 |
| CLOPIMEN-75 Clopidogrel Tablets IP 75 mg | T-2405321Mfg 2024-05 · Exp 2026-04 | sample received does not conform to I.P. 2022 for the reason stated under description and with respect to the tests for Related substances" and "Assay.Assay | CDTL, MumbaiCDSCO lab | Sep 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.